| Tag | Content |
|---|
EnhancerAtlas ID | HS105-04873 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr1:151608060-151609090 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr1:151608918-151608928 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr1:151608918-151608928 | GGCACGTGCC | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09648 | chr1:151605995-151609627 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 151608258 | 151608600 | | chr1 | 151608065 | 151608239 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I151633 | chr1 | 151605996 | 151609627 |
|
Enhancer Sequence | CCTCTTAATT CTTCAGGAAG GAGGGCCCTT TTTCAAATCA GACATCCTGG GGTTTTTACT 60
GACCTTATTT CATTCTCTGA AGAATGAAGG AATTTCCCAC TTTGTAGTAA GTCATGGAAT 120
GTATAGCATT CCTTCTATAG TTGAACCAGA TAAATATTAG CAAGTCTGTT TAGAATATGA 180
CACTGGAAGT TTTTTCCTGT CTTTTTTTAA AAGAGGTTTT TGGAATTATA GTCAATCTGA 240
AACTTGGTCT TACTAATAAA GAAGTGAAAC CTAAGTGAGC TCCCTTGCTC CCTGATGGCT 300
CTTGGTATAA GTCTCACTTA AGTTTCTCTG ACGATTTTCA GGGTTTATTT TTGTGAGTGA 360
CCCAAGGAAC GGTGTATTTT GATTTGAAAA CTGAATGGGT GGAGGTGTGT ATTGAAAGCA 420
ATAGTTCTGA ATCTTTTTGG AGTTTATATA CTCCTTTTTG AAGCTGATGA AAGCTAGGGA 480
AACTCCCCAG AAAAAAACGC ATAATAGGCA CATAAAAAGA ATTTTACATA CAAATTTTGT 540
AGATCCAGTG ACTCTCAAGT CTACCAACAG AGTGCCCTAG ATAAAAAATT CTTTAAAGGA 600
AAAAAAATCA GGGAACCGAA AAGTAAGATT TGAGCATCAG TTTTTATTTT TCACAAATGT 660
GCGTTTCATA AAATTGATTG CATTAACAGA AATTTTGTTT TGGTATTTAA GATTTTATTT 720
TATTTCATTT TTTAAAAAAC AGGATCTTCT TTTGTAACCC AGGCTGGAGT GCAGTGGCAT 780
GATCTAGCTC ACTGCAGCCT TGAACTCCCA GGCTCAGGTG TTCTTCCCAG CTCAGCCTCC 840
CAAGTAGCTG GAACTATAGG CACGTGCCAC CAGGCCTGGC TAATCTTTTG GTATATTTCG 900
TATAGAGACG GGGTTTCACC ATGTTGCCCA GGCTGGTCTC AAACTCCTGA ACTCAAGTGA 960
TTCATCTGCC TTGGCCTCCT AAAGTGCTGG GATTACAGGT GTGAGCCACA CTGTGCCTAG 1020
CCTGTATCCA 1030
|
